Video instruction may cut medication errors in kidney transplant patients
NCT ID NCT07592624
First seen Jun 27, 2026 · Last updated Sep 17, 2026 · Updated 2 times
Summary
This study tests whether an instructional video about medication management can reduce errors in kidney transplant patients compared to standard verbal instructions. About 308 adult patients at Erasmus MC will be randomly assigned to watch the video or receive usual teaching. Researchers will track medication mistakes during hospital stays and follow up with questionnaires at the outpatient clinic.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- instructional video about medication administration
- What this could lead to
- If it works, this could point toward a simple, scalable way to reduce medication errors in kidney transplant patients.
- What could go wrong
- This is a small, single-center study that has not yet started. The video may not significantly improve adherence over standard care, and results may not apply to other hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 308 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2027
An estimate. Start dates often move.
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The patient is able to take the medication independently or with the help of someone else (professionals not included). * After admission, the patient is discharged to their own home or home of friend/relative. * The patient had a follow up at the outpatient clinic in the Erasmus Medical Center for at least one year after transplantation. * The patient is able to read the medication list or an illiteracy-friendly medication list. Exclusion Criteria: * Patients under 18 years of age * Patients who got discharged with a medication dispenser * Refusal to participate in the study. * Cognitive impairments that hinder participation. * Patients and/or family who can not understand (language barrier) the instructional video.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Adult are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Erasmus Medical Center
Rotterdam, 3015GD, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New fluid aims to keep donated kidneys healthier
- Pfizer tests RSV vaccine aimed at older adults
- Can a Pharmacist's talk help COPD patients breathe easier and spend less?
- Can a phone app and a coach keep a new kidney healthier?
- A new tool aims to predict and prevent living kidney donor Drop-Out
- Can digital tools and training help more kidney patients get transplants?